Related Experiment Video
Updated: Jun 5, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
Enhanced dispersion of repolarization explains increased arrhythmogenesis in severe versus therapeutic hypothermia
Joseph S Piktel1, Darwin Jeyaraj, Tamer H Said
1The Heart and Vascular Research Center, MetroHealth Campus, Case Western Reserve University, Cleveland, OH, USA. jpiktel@metrohealth.org
Insights
Therapeutic hypothermia (TH) increases the dispersion of repolarization (DOR), a key factor in cardiac arrhythmias. DOR is dependent on cooling depth and rewarming, impacting clinical TH protocols.
Area of Science:
- Cardiovascular Electrophysiology
- Cardiac Arrhythmia Mechanisms
- Therapeutic Hypothermia
Background:
- Hypothermia is known to be proarrhythmic.
- Increasing use of therapeutic hypothermia (TH) necessitates understanding its effects on cardiac electrophysiology.
- Investigating hypothermia's impact on arrhythmia substrates is crucial.
Purpose of the Study:
- To test the hypothesis that hypothermia-enhanced transmural dispersion of repolarization (DOR) causes arrhythmias.
- To investigate how hypothermia depth, cooling/rewarming rates, and temperature changes affect arrhythmia substrates.
Main Methods:
- Optical action potentials recorded from canine left ventricular wedge preparations.
- Electrophysiological parameters analyzed at varying hypothermia depths (36°C, 26°C, 32°C).
- Comparison of cooling versus rewarming effects on DOR and conduction velocity.
Main Results:
- Cooling to 26°C significantly increased DOR (26±4 ms to 93±18 ms) and decreased conduction velocity (35±5 cm/s to 22±5 cm/s).
- Rewarming to 36°C resulted in persistent DOR prolongation, while conduction velocity normalized.
- Conduction block, reentry, and ventricular arrhythmias (VF/VT) were observed, particularly during rewarming.
Conclusions:
- Hypothermia amplifies DOR, serving as a mechanism for cardiac arrhythmogenesis.
- DOR is directly dependent on the depth of cooling and rewarming.
- Findings provide insights into clinical TH and inform protocols for managing arrhythmia risk.
Background:
Hypothermia is proarrhythmic, and, as the use of therapeutic hypothermia (TH) increases, it is critically important to understand the electrophysiological effects of hypothermia on cardiac myocytes and arrhythmia substrates. We tested the hypothesis that hypothermia-enhanced transmural dispersion of repolarization (DOR) is a mechanism of arrhythmogenesis in hypothermia. In addition, we investigated whether the degree of hypothermia, the rate of temperature change, and cooling versus rewarming would alter hypothermia-induced arrhythmia substrates.
Methods And Results:
Optical action potentials were recorded from cells spanning the transmural wall of canine left ventricular wedge preparations at baseline (36°C), during cooling and during rewarming. Electrophysiological parameters were examined while varying the depth of hypothermia. On cooling to 26°C, DOR increased from 26±4 ms to 93±18 ms (P=0.021); conduction velocity decreased from 35±5 cm/s to 22±5 cm/s (P=0.010). On rewarming to 36°C, DOR remained prolonged, whereas conduction velocity returned to baseline. Conduction block and reentry was observed in all severe hypothermia preparations. Ventricular fibrillation/ventricular tachycardia was seen more during rewarming (4/5) versus cooling (2/6). In TH (n=7), cooling to 32°C mildly increased DOR (31±6 to 50±9, P=0.012), with return to baseline on rewarming and was associated with decreased arrhythmia susceptibility. Increased rate of cooling did not further enhance DOR or arrhythmogenesis.
Conclusions:
Hypothermia amplifies DOR and is a mechanism for arrhythmogenesis. DOR is directly dependent on the depth of cooling and rewarming. This provides insight into the clinical observation of a low incidence of arrhythmias in TH and has implications for protocols for the clinical application of TH.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Decreased Body Temperature
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

